Herceptin

Company
Genentech

Approval Status
Approved October 1998

Treatment for
Breast cancer

Possible similar drugs
Herceptin

Areas
Diabetes / Endocrinology , Gastrointestinal , Pregnancy & Gynecology , Cancer & Oncology

Herceptin (trastuzumab) is used as a second- or third-line therapy for patients with metastatic breast cancer.

Herceptin_485 Drug Information

The Herceptin_485 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top